Stanford stem cell experts highlight “inherent flaw” in drug development system – Scope (blog)
|
Stanford stem cell experts highlight “inherent flaw” in drug development system
Scope (blog) Academic institutions are in a much better position than pharmaceutical companies to make the best decisions about which therapies deserve further development. That was the underlying message from a pair of Stanford researchers at a panel on stem cell … |
